Maniatis, 1995). The putative transcriptional regulatory role of the closely related HMGI-C protein has not been The expression of the high mobility group I (HMGI)-C
defined as yet. Overexpression of HMGI proteins has been detected in chromatin component was shown previously to be several experimental and human tumors, including thyroid essential for the establishment of the neoplastic phenocarcinomas (Bussemakers et al., 1991; Ram et al., 1993 ; type in retrovirally transformed thyroid cell lines. To Tamimi et al., 1993; Chiappetta et al., 1995; Fedele et al. , identify possible targets of the HMGI-C gene product, 1996) . Recently, an antisense RNA strategy allowed the we have analyzed the AP-1 complex in normal, fully establishment of the causal role of the HMGI-C gene transformed and antisense HMGI-C-expressing rat product in thyroid cell transformation. The stable antisense thyroid cells. We show that neoplastic transformation RNA expression blocks HMGI-C protein synthesis and is associated with a drastic increase in AP-1 activity, prevents retroviral transformation by the v-mos and v-Kiwhich reflects multiple compositional changes. The ras oncogenes. Interestingly, two different cell lines costrongest effect is represented by the dramatic junB expressing either the v-mos or v-Ki-ras oncogene and the and fra-1 gene induction, which is prevented in cell antisense HMGI-C (HMGI-C-as cell lines) exhibit an lines expressing the antisense HMGI-C. These results intermediate phenotype, characterized both by the inhibiindicate that the HMGI-C gene product is essential for tion of transformation parameters and by the extinction the junB and fra-1 transcriptional induction associated of the thyroid-specific differentiation markers (Berlingieri with neoplastic transformation. The inhibition of Fra-1 et al., 1995) . Such a cellular system provides a tool to protein synthesis by stable transfection with a fra-1 identify possible transcriptional targets of the HMGI-C antisense RNA vector significantly reduces the maliggene product involved in the nuclear response to the nant phenotype of the transformed thyroid cells, oncogene-dependent transduction pathways. indicating a pivotal role for the fra-1 gene product inIntroduction the four Fos family members (c-Fos, FosB, Fra-1 and Thyroid cell transformation represents a model system for Fra-2), which give rise to a large variety of homo-and the study of epithelial tumorigenesis. Two rat thyroid heterodimers, binding to very similar or identical DNA epithelial cell lines, which retain the typical markers of motifs (Abate and Curran, 1990 ; Ransone and Verma, thyroid differentiation, have been infected by several 1990; Angel and The combinatorial diversity oncogenes, generating a variety of de-differentiated or of the dimers depends on the expression level of the transformed phenotypes, which recapitulate the broad individual components in distinct cell types, in different spectrum of differentiative and proliferative features of phases of the cell cycle and in different environmental situations. human thyroid cancer (Fusco et al., 1985 (Fusco et al., , 1987 Berlingieri The rapid control of AP-1 activity is exerted by posttranslational modifications, mainly phosphorylation, in response to the MAP kinase transduction pathways (reviewed in Davis, 1994; Karin, 1995) . Phosphorylation has been shown to control the function of the AP-1 components by different mechanisms, including the DNAbinding activity (Boyle et al., 1991; Papavassiliou et al., 1995) , the recruitment of the CBP-p300 integrator complex (Arias et al., 1994; Bannister et al., 1995) and the metabolic stability of the proteins (Gruda et al., 1994; Okazaki and Sagata, 1995) .
The role of AP-1 in transformation was shown historically by the isolation of retroviruses carrying the v-jun and v-fos oncogenes. Subsequently, the oncogenic potential of c-Jun (Schutte et al., 1989) , JunB (Van Amsterdam et al., 1994) , c-Fos (Miller et al., 1984) and FosB (Wisdom et al., 1992) has been shown by ectopic overexpression or by cooperation with other oncogene products. Conversely, JunD has been characterized as a negative regulator of fibroblast growth, capable of partially antagonizing the ras-mediated transformation (Pfarr et al., 1994) . The The AP-1 target genes are characterized by the presence of functional TPA-responsive elements (TREs), which are often part of complex regulatory elements. For instance, Ki-ras oncogene. The binding activity in different nuclear AP-1 frequently has been found to cooperate with another extracts was normalized by using an oligonucleotide probe class of ras-responsive transcription factors, the Ets family for the ubiquitous Sp1 transcription factor ( Figure 1B ). proteins, in controlling the expression of genes important
The in vitro binding to the collagenase TRE (collTRE) for the malignant phenotype, like those encoding the AP-1 site was dramatically increased, in both the v-mosextracellular matrix-degrading proteases (Gutman and and in the v-Ki-ras-transformed cell lines (PC MPSV Wasylyk, 1991) . compared with PC Cl.3, and FRTL-5 KiMSV compared Here we describe the effect of neoplastic transformation with FRTL-5 Cl.2, Figure 1A ). The collTRE AP-1 complex and HMGI-C protein inhibition on composition, expression was significantly decreased (3-to 5-fold, by phosphorof individual components and activity of the AP-1 complex imager analysis) in the HMGI-C-as cell lines (PC-C-asin rat thyroid cells. We show that the drastic transform-MPSV and FRTL-5/C-as/KiMSV) with respect to the fully ation-dependent accumulation of JunB and Fra-1 depends transformed cell lines. As a control of the specificity of upon changes at the mRNA level, which are prevented in the antisense effect, we also examined the AP-1 activity the absence of the HMGI-C gene product. To address the in the cell lines expressing the antisense HMGI-C but not role of Fra-1 in thyroid cell transformation, we have the retroviral oncogenes, in which the HMGI-C gene adopted an antisense RNA stategy, and shown that the product is absent. As expected, these cell lines (PC/C-as decrease of Fra-1 protein synthesis greatly reduces the and FRTL-5/C-as) exhibited the same low level of AP-1 transformed phenotype of thyroid cells.
binding detected in the parental PC Cl.3 and FRTL-5 Cl.2 cells.
Results
To investigate a possible difference in DNA binding stability, we then analyzed the kinetics of dissociation
Oncogene-mediated AP-1 induction is decreased in
(off-rate) of the AP-1 complexes expressed in the fully the absence of HMGI-C protein transformed cell lines compared with the complexes We first investigated, by electrophoretic mobility shift detected in the antisense HMGI-C-expressing cell lines assay (EMSA), AP-1 binding in different cell lines, (see Figure 2A for the PC-derived cell lines, and Figure including normal rat thyroid cells 2B for the FRTL-5-derived lines). As shown by phosphorCl.2), retrovirally transformed cells (PC MPSV and imager quantitation ( Figure 2C ), the dissociation rate of FRTL-5 KiMSV) and retrovirally infected cell lines the protein-DNA complex formed by the nuclear proteins expressing both the oncogene and the antisense HMGI-C of fully transformed cells (PC MPSV and FRTL-5 KiMSV) (HMGI-C-as cell lines: PC/C-as/MPSV and FRTL-5/C-as/ was slower than the dissociation rate of the complex KiMSV, Figure 1A ). As reported (Fusco et al., 1985, formed by the nuclear proteins of the antisense-expressing 1987), PC MPSV cells were obtained by infection with cells (PC/C-as/MPSV and FRTL-5/C-as/KiMSV), sugthe myeloproliferative sarcoma virus, carrying the v-mos gesting a significant difference in stability of the in vivo oncogene, while FRTL-5 KiMSV cells were obtained by infection with Kirsten murine sarcoma virus, carrying the interaction. These results suggested a change in the com- revealed that the AP-1 complex of the PC MPSV cells was completely supershifted by the anti-Fra-1 antibodies ( Figure 3B ). Interestingly, a different pattern was observed position of AP-1 complexes caused by transformation and modified by the antisense HMGI-C expression.
in the antisense HMGI-C-expressing cells. The relative intensity of the supershifted complexes detected by the anti-c-Jun, anti-JunB and anti-JunD antibodies was similar AP-1 compositional changes in transformed thyroid cells to that observed in the normal cells; however, unlike the normal and fully transformed cell line, only a fraction of Antibody supershift analysis was performed to determine the composition of the complexes detected by EMSA. To the complex was supershifted by the anti-Fra-1 antibodies ( Figure 3C ). visualize the small amount of gel-retarded complex formed by the PC Cl.3 and FRTL-5 Cl.2 nuclear proteins, a longer
The analysis of the AP-1 components in the v-Kiras-transformed cell line revealed interesting differences. autoradiographic exposure is shown. In the parental PC Cl.3 cells, the collTRE-bound complex was almost comWhile the supershifted complexes in the FRTL-5 Cl.2 cells were identical to those detected in the PC Cl.3 cells pletely supershifted by the anti-JunD antibodies; a minor supershift was also detected by anti-c-Jun and anti-JunB (compare Figure 3A and AЈ), the v-Ki-ras-transformed cells (FRTL-5 KiMSV) exhibited a different pattern of and, to a lesser extent, by the anti-Fra-2 antibodies ( Figure  3A ). The AP-1 complex detected in the v-mos-transformed supershift, evidenced by the antibodies recognizing the Fos family members. We found that, in addition to the cells exhibited a different supershift pattern. The antibodies selectively recognizing Jun family members revealed that major supershift detected by anti-Fra-1, a significant amount of complex was also supershifted by the antithe upper half of the broad gel retardation product was FosB antibodies ( Figure 3BЈ ). Pre-incubation of nuclear proteins with both antibodies allowed the detection of a complete supershift (not shown), indicating that the AP-1 activity in the v-Ki-ras-transformed cell line is produced by heterodimers containing two different Fos-related proteins, FosB and Fra-1, instead of only Fra-1 as in the v-mostransformed cells. We analyzed this point further, and found that the observed difference depends on the transforming oncogene rather than the parental cell line, since the Ki-MSV-infected PC cells behave identically to the Ki-MSV-infected FRTL-5 Cl.2 cells (data not shown). An intermediate pattern, between that of normal and fully transformed cells, was detected in the antisense HMGI-Cexpressing cell line (FRTL-5/C-as/KiMSV): the anti-Fra-1-supershifted complex was decreased, while the anti-FosBsupershifted complex was absent, with respect to fully transformed cells ( Figure 3CЈ ). The analysis of the Junrelated components revealed qualitatively similar modifications with respect to the v-mos-transformed cell line, showing that the JunD/JunB ratio was reverted in the strictly correlated with changes at the mRNA level Immunoblotting analysis with the JunD-selective antiTo characterize the regulatory changes associated with the body ( Figure 4A ) allowed detection of a 41 kDa band, in different AP-1 composition, we analyzed the protein and agreement with the size of JunD, and an additional 37 kDa mRNA levels of the individual AP-1 components identified band, with the same intensity as the upper band. Both by supershift assays.
polypeptides were specific, since they were not detected Western blotting analysis showed that the level of the when the antibodies were pre-incubated with an excess of p39 c-Jun protein was significantly increased in both As for the c-jun mRNA, the analysis of the junD analyzed ( Figure 4B ). As shown by phosphorimager transcript ( Figure 4B and C) revealed a striking absence quantitation normalized by the GAPDH internal control of correlation with the immunoblotting data. The results ( Figure 4C ), the c-jun mRNA was only slightly increased were slightly different for the PC-derived and the FRTL-5-in the two transformed cell lines and, surprisingly, it was derived cell lines. Unexpectedly, the junD transcript was increased further in the HMGI-C-as cell lines, with a decreased slightly both in the v-mos-transformed cells (PC larger effect in the v-mos-infected cell line (PC/C-as/ MPSV) and in the v-mos-infected HMGI-C-as cell line MPSV). These results indicate a partial correlation, or no (PC/C-as/MPSV, Figure 4C ). In the v-Ki-ras-transformed correlation, with the corresponding protein levels detected cells, the level of the junD mRNA was not affected significantly by the expression of the oncogene alone by immunoblotting. Therefore, the changes at the protein Figure 4A , except that JunB-, Fra-1-and FosB-specific antibodies were utilized. A short exposure was chosen to visualize fully the dramatic fold-induction of the three components in the transformed cell lines. The prolonged exposure of the JunB immunoblot also allowed detection of the small amount of protein expressed in the FRTL-5/C-as/KiMSV cell line (not shown). The blotted proteins were stained with Red-Ponceau. The molecular weight (kDa) of size markers is indicated on the sides. The brackets indicate the broad JunB (~38 kDa) and Fra-1 (~38 kDa) immunoblotting products. The arrow indicates FosB (41 kDa). (B) Northern blot analysis of junB, fra-1 and fosB mRNA. Total RNA extracted from the indicated cell lines was hybridized to the c-jun, junD and junB radiolabeled cDNAs, and then with a rat GAPDH probe, as a control for RNA loading. In the fosB panel, the arrow indicates the mRNA species, in agreement with the predicted size (4.5 kb) of fosB mRNA; the asterisk indicates a larger fosB-related mRNA, which might represent an unspliced precursor.
(FRTL-5 KiMSV), but it was decreased significantly in Fra-1, such an AP-1 component should be expressed in excess with respect to each of the Jun heterodimeric the cell line expressing both v-Ki-ras and the antisense HMGI-C (FRTL-5/C-as/KiMSV, Figure 4C ). However, it partners. Similarly to JunB, the larger increase of Fra-1 in the v-mos-transformed cells could be only partially must be emphasized that, independently of the variations in mRNA level, the expression pattern of the JunD protein antagonized in the PC/C-as/MPSV cell line. This was particularly evident from the result of Northern hybridizin the PC-derived cell lines was similar to that detected in the FRTL-5-derived cell lines, suggesting that JunD, like ation ( Figure 5B) , showing that the dramatic increase in fra-1 mRNA was suppressed completely by antisense c-Jun, is regulated mainly at the post-transcriptional level.
HMGI-C in the v-Ki-ras-expressing cells, but not in the v-mos-expressing cell line (compare FRTL-5/C-as/KiMSV
Expression of junB, fra-1 and fosB in transformed thyroid cells: the strong oncogene-dependent and PC/C-as/MPSV). The supershift analysis of Figure  3BЈ showed that the TRE-bound complex in the FRTL-5 induction requires the HMGI-C gene product A different picture was obtained by analyzing the expresKiMSV cells contains not only Fra-1 but also FosB, as a Jun heterodimeric partner. Western blotting showed that, sion of the other components (junB, fra-1 and fosB) of the complexes identified by supershift analysis.
with a smaller induction than Fra-1, FosB, which is undetectable in FRTL-5 cells, was overexpressed significThe level of the 38 kDa JunB polypeptide was increased dramatically by transformation, with a more pronounced antly in FRTL-5 KiMSV cells, and its accumulation was totally prevented in the FRTL-5/C-as/KiMSV cell line effect in the v-mos-transformed cells compared with the v-Ki-ras-transformed cells ( Figure 5A ). While the increase ( Figure 5A ). The levels of the 41 kDa FosB protein were paralleled by the mRNA levels ( Figure 5B) ; interestingly, in JunB was totally prevented by the HMGI-C inhibition in the v-Ki-ras-expressing cells, a small amount of protein the 4500 nucleotide fosB mRNA in the ras-transformed cells was associated with the appearance of a large was still detected in the PC/C-as/MPSV cells. A good correlation was observed between the levels of the junB RNA species (~8000 nucleotides), possibly reflecting the accumulation of an unspliced precursor. transcript and the amount of protein detected by immunoblotting. Again, while the v-Ki-ras-dependent increase in
We also examined the expression of the two Fos family members (c-Fos and Fra-2) which did not exhibit junB mRNA was antagonized completely in the HMGI-Cas cells, the effect of the antisense HMGI-C was partial significant variations on supershift analysis. The c-fos gene product was undetectable in all six normal and in the v-mos-transformed cells.
We then examined the expression of the two fos-related transformed cell lines; as a positive control for c-Fos expression, we utilized nuclear proteins from phorbol components, fra-1 and fosB, detected by the supershift analysis. Immunoblotting results showed a dramatic ester-stimulated normal cells (PC Cl.3), which allowed detection of the highly modified TPA-induced 55 kDa increase in Fra-1, even more pronounced than JunB, in the v-mos transformed cells, and a smaller accumulation c-Fos ( Figure 6A ). The analysis of the other Fos-related component revealed an equivalent low level of expression in the v-Ki-ras transformed cell line ( Figure 5A ). Indeed, a larger increase of the Fra-1 protein was predictable on of the 38 kDa Fra-2 protein in the six cell lines ( Figure 6B ). Since the immunoblotting result allowed us to establish the basis of the results of Figure 3B , showing that, since all the AP-1 dimers in the v-mos transformed cells contain the absence of variations of the Sp1 protein level in the collagenase and transin/stromelysin, and the angiogenic vascular endothelial growth factor (VEGF). The collagenase mRNA, undetectable in the normal cell lines, was induced dramatically in both PC MPSV and FRTL-5 KiMSV cells, reaching the highest expression in the v-mos-transformed cells ( Figure 7B ). The collagenase transcript was reduced significantly in both the antisense HMGI-C-expressing cell lines (PC/C-as/MPSV and FRTL-5/C-as/KiMSV). A strikingly identical expression pattern was detected by analyzing the stromelysin mRNA level ( Figure 7C ). The analysis of VEGF gene expression also revealed a significant up-regulation in both transformed cell lines ( Figure 7D) . Remarkably, the counteracting effect of HMGI-C inhibition was quantitatively different in the two cell lines: while collagenase, stromelysin and VEGF expression was almost completely suppressed by HMGI-C inhibition in the v-Ki-ras-expressing line (FRTL-5/C-as/KiMSV), the effect was smaller in the v-mos-expressing cells (PC/C-as/MPSV). shown in Figure 8B . Two clones (PC MPSV/Fra1-as Cl.3 and Cl.4) derived from the PC MPSV cell line and two clones (FRTL-5 KiMSV/Fra1-as Cl.1 and Cl.8) derived six cell lines ( Figure 6C ), anti-Sp1 antibodies were used as a control for equal loading of the proteins transferred from the FRTL-5 KiMSV cell line exhibited an almost complete inhibition of Fra-1 protein expression. The by Western blotting.
inhibition of Fra-1 was associated with a dramatic decrease in collTRE binding activity in the selected cell clones
Activity of AP-1 target genes in normal, transformed and HMGI-C-as cell lines
( Figure 8C ). While most of the geneticin-resistant clones were indisTo determine the functional consequences of the AP-1 compositional changes, we tested by transfection analysis tinguishable from the parental transformed cell lines, the cell clones expressing the lowest Fra-1 levels (PC MPSV/ the activity of a reporter construct, containing the consensus collTRE fused to a heterologous minimal promoter.
Fra1-as Cl.3 and Cl.4 and FRTL-5 KiMSV/Fra1-as Cl.1 and Cl.8) exhibited a different morphology. These clones For better comparison, the same value was assigned to the basal level of TRE-CAT activity detected in the PC were characterized by a rather epithelial appearance, with respect to the highly refractile and round (PC MPSV) Cl.3 and FRTL-5 Cl.2 cell lines. The results ( Figure 7A ) indicate a strong activation (~10-fold) of the TRE-CAT morphology of the fully transformed cell lines (compare PC MPSV/Fra1-as Cl.3 with PC MPSV, and FRTL-5 reporter in the v-mos transformed cell line (PC MPSV), and a smaller induction (~5-fold) in the ras-transformed KiMSV/Fra1-as Cl.8 with FRTL-5 KiMSV in Figure 8D ). However, the antisense fra-1-expressing cell lines were cells (FRTL-5 KiMSV). Both HMGI-C-as cell lines exhibited a significantly decreased collTRE activity, with an~3-still morphologically distinct from the normal cell lines (PC Cl.3 and FRTL-5 Cl.2, Figure 8D ). The effect of fold reduction in both HMGI-C-as cell lines (PC/C-as/ MPSV and FRTL-5/C-as/KiMSV), which still exhibited a Fra-1 inhibition on the transformed phenotype was evaluated further by testing the anchorage-independent growth. higher activity (from 2-to 6-fold) compared with the parental cells.
The results indicate that the ability to form colonies in soft agar was significantly affected in the PC MPSVWe then examined the expression of several AP-1 target genes implicated in the transformed phenotype, including derived cell clones expressing the antisense fra-1 ( Figure  8E and Table I ). Both the morphology and the soft agar two extracellular matrix-degrading proteases, type-I plating efficiency indicate the partial reversion of the thyroid cell transformation. The results of the antisensemediated inhibition, obtained by the same stategy utilized transformed phenotype. Similar results were obtained with both the FRTL-5 KiMSV-derived cell clones expressing for Fra-1, indicate that the junB gene product is also necessary for the establishment of the fully transformed the antisense fra-1, while the retroviral-mediated overexpression of the fra-1 sense RNA did not affect the phenotype, although with a smaller effect on anchorageindependent growth compared with the Fra-1 inhibition growth in soft agar and the morphology of the PC MPSV and FRTL-5 KiMSV cell lines (Table I and data  (Table I) . Therefore, fra-1, and possibly junB, overexpression represents an essential event during thyroid cell not shown).
We have also analyzed the role played by JunB in transformation, independently of the transforming oncogene. Finally, to test whether the increased levels of Fra-1 or JunB might affect the growth properties of normal thyroid cells, we analyzed the effect of the overexpression of each of these two AP-1 components by stable transfection in PC Cl.3 cells. The expression of Fra-1 or JunB, in the sense orientation, was driven by the long terminal repeat (LTR) of the pMV-7 vector ( Figure 8A ). The geneticinresistant cell clones were isolated and assayed for soft agar plating efficiency. The results indicate the absence of any effect on the anchorage-independent cell growth (Table I) .
Discussion
An important role for HMGI proteins in tumorigenesis is indicated by several lines of evidence. The altered regulation of the HMGI chromatin components is determined not only by overexpression, as in thyroid and other epithelial-derived tumors (Bussemakers et al., 1991; Ram et al., 1993; Tamimi et al., 1993; Fedele et al., 1996) , but also by chromosomal rearrangements, detected for the HMGI-C gene in various mesenchymal tumors (Ashar et al., 1995; Schoenmakers et al., 1995) . The resulting chimeric proteins contain the HMGI-C DNA-binding domains (AT hooks) fused to heterologous protein sequences. In addition, the recent identification of gene rearrangements involving the chromosomal region 5Ј to HMGI-C suggests that transcriptional activation of the gene and overexpression of an intact HMGI-C protein can have a causal role in tumorigenesis. Therefore, it is important to identify the genomic targets Fig. 7 . Activity of the collTRE reporter construct and AP-1 target genes in normal, fully transformed and HMGI-C-as cell lines. (A) The CAT reporter construct containing five copies of the collagenase AP-1 element (5ϫ-collTRE) fused to the thymidine kinase promoter was transfected into the six thyroid cell lines, as indicated. CAT activity was assayed 40 h after transfection; the results represent the average of five independent experiments. All transfections were performed using a CMV-luciferase internal control vector to normalize for the variation of transfection efficiency between the different cell lines. The diagram shows the relative CAT activity, determined by assigning the same basal level to the PC Cl.3 and FRTL-5 Cl.2 parental cell lines. (B and C) The mRNA level of type 1 collagenase and transin/ stromelysin was determined by RT-PCR (for details see Materials and methods). Both type-1 collagenase and stromelysin cDNAs were co-amplified with GAPDH as an internal control. Bands of comparable intensity, obtained by the rat GAPDH sequence-specific primers, suggest comparable amplification of all samples. No bands are seen in non-reverse-transcribed RNAs, excluding a possible DNA contamination. The position of size markers is shown on the left; the arrows on the right indicate the position of PCR products: 721 bp for type-1 collagenase (B) and 430 bp for transin/stromelysin (C), in agreement with the expected size. (D) The VEGF mRNA was detected by Northern hybridization. Fifteen μg of total RNA was loaded for each cell line, and the filter was first hybridized with a human VEGF radiolabeled cDNA probe, and then with a rat GADPH probe. cell lines. The increased half-life of the Jun proteins might be a consequence of the heterodimerization by itself, or, since Fra-1 is phosphorylated extensively and probably of the HMGI proteins and understand their role in the establishment of the transformed phenotype.
represents an in vivo substrate for MAP kinases (Gruda et al., 1994) , the phosphorylation-dependent stabilization In this work, we have characterized the compositional changes of the AP-1 complex in a rat thyroid cell system of Fra-1 might affect the turnover of its heterodimeric partners. in which retroviral transformation could be suppressed by the antisense-mediated inhibition of HMGI-C protein.
Differing from c-Jun and JunD, the dramatic accumulation of both JunB and Fra-1 is associated with a strong Among complex regulatory changes, we have shown that the junB and the fra-1 genes are strongly induced by transcriptional induction, which tightly correlates with tumorigenicity, being higher in the more malignant v-mostransformation and that the induction is antagonized by HMGI-C inhibition, thus identifying potential targets of transformed cell line than in the v-Ki-ras transformed cells. It has been shown recently that the overexpression of the HMGI-C gene product.
To understand the role of Fra-1 in transformation, we the HMGI-C chromatin component is required for the establishment of the transformed phenotype of thyroid have also analyzed the effect of its functional inhibition, and shown that the Fra-1 overexpression is essential for cells (Berlingieri et al., 1995) . We show here that junB and fra-1 gene expression tightly parallels HMGI-C the fully transformed phenotype.
The increased AP-1 activity in transformed thyroid cells expression in the fully transformed cells and in the HMGI-C-as cell lines, in which the HMGI-C gene is reflects multiple changes of the individual components, determined by different mechanisms. Both c-Jun and inhibited by an antisense construct. The observed correlation does not simply reflect the general inhibition of JunD, but not JunB, are expressed in exponentially growing normal thyroid cells, in agreement with the results pretransformation markers caused by HMGI-C suppression, but appears to be rather specific for JunB and Fra-1 (and viously reported for NIH 3T3 fibroblasts (Pfarr et al., 1994) . The accumulation of JunD in transformed thyroid FosB in the v-Ki-ras-transformed cells), since the HMGI-C inhibition affects the mRNA level of other AP-1 componcells is in contrast to the results obtained in ras-transformed mouse fibroblasts (Pfarr et al., 1994; our unpublished ents (c-Jun and JunD) differently. Therefore, our results identify the junB and fra-1 genes as potential targets of data), in which JunD overexpression has been found to antagonize ras-mediated transformation. Moreover, it has the HMGI-C gene product.
The detailed functional analysis of interferon-β and been shown recently that in rat embryo fibroblasts not only c-jun and junB, but also junD can cooperate with ras other inducible elements allowed the establishment of an 'architectural' role played by the HMG(Y) proteins, which for focus formation. To explain the apparent discrepancy, it has been proposed that the junD oncogenic potential might mediate multiple cooperative interactions between various transcription factors, allowing the assembly of complex be related to its cell type-specific dimerization partners (Vandel et al., 1996) . enhancers (enhanceosomes) (Thanos and Maniatis, 1995) . It has been shown recently that the close structural Both the v-mos and v-Ki-ras oncogenes drastically enhance the levels of JunB, JunD and, to a lesser extent, similarity between HMGI-C and HMGI(Y) gene products results in the same multivalent DNA-binding specificity. c-Jun. The accumulation of both c-Jun and JunD in Importantly, it has been reported that the HMG-I proteins cells, showing that Fra-1 (or JunB) overexpression is necessary but not sufficient for the establishment of the bind with high affinity to the AT tracts of the serum-and TPA-responsive element of the downstream JunB enhancer transformed phenotype. These results might reflect the complexity of epithelial tumorigenesis, with respect to (Maher and Nathans, 1996) . Therefore, we speculate that the decrease in transformation-dependent junB induction mesenchymal cell transformation. Our analysis also indicates the important role played by JunB in thyroid cell might reflect the lack of activation of the junB growthresponsive enhancer in cells expressing antisense transformation. The antisense-mediated inhibition of junB resulted in a smaller effect on the transformed phenotype; HMGI-C.
It has been reported that the transcriptional regulation this result might reflect the residual activity of the c-JunFra-1 and JunD-Fra-1 heterodimers in the antisense JunBof fra-1 depends largely on an AP-1-responsive enhancer in the first intron of the gene (Bergers et al., 1995) . expressing cell lines (Table I and data not shown). Further studies will be required to establish the individual role of Accordingly, the serum inducibility of fra-1 is reduced in fibroblasts lacking c-fos or c-jun. Moreover, the fra-1 gene the three Jun family members in the oncogenic transformation of thyroid cells. is induced by the ectopic overexpression of various AP-1 components (c-Fos, FosB, Fra-1 and c-Jun). Therefore, it
Our recent results further support the role of fra-1 in the transformed phenotype. In fact we have detected fra-1 is likely that the oncogene-dependent induction of Fra-1 is consequent to the induction of other AP-1 components overexpression in rat thyroid cell lines transformed by other oncogenes, and in human thyroid carcinoma cell taking place during the early steps in the establishment of the transformed phenotype. It can be postulated that the lines (data not shown). Moreover, the detection of Fra-1 in various tumors of epithelial origin (S.Battista et al., lack of fra-1 gene induction might represent a consequence of the inhibition of junB induction in the cells expressing manuscript in preparation) suggests that fra-1 overexpression is a general and necessary event in neoplastic cell antisense HMGI-C. Alternatively, it can be speculated that HMG-I binding sequences might be present within the transformation. Finally, while this manuscript was under revision, a fra-1 regulatory region, and essential for the full activation of the AP-1-responsive enhancer in the first intron of the recent study on the AP-1 compositional changes in rastransformed NIH 3T3 fibroblasts strongly confirmed our gene. Experiments are in progress to understand these regulatory aspects.
results on the crucial role of Fra-1 in oncogenic transformation (Mechta et al., 1997) . The strongly increased AP-1 binding of the Fra-1-containing heterodimers results in the increased activity of a transfected AP-1 reporter, which correlates with the
Materials and methods
induction of prototype AP-1 targets, such as the collagenase (Angel et al., 1987) , stromelysin (Buttice et al., Cell culture and transfection analysis 1991) and VEGF genes (Saez et al., 1995) , in both the PC Cl.3 rat thyroid cells are derived from 18-month-old and FRTL-5 transformed cell lines. On the basis of the well established cells from 3-to 4-week old normal Fisher rats (Fusco et al., 1987; Berlingieri et al., 1988) . The PC/C-as, PC MPSV, PC/C-as/MPSV, correlation with the invasive and metastatic potential FRTL-5/C-as, FRTL-5 KiMSV and FRTL-5/C-as/KiMSV cell lines have (Matrisian, 1994) , the oncogene-dependent induction of been described (Berlingieri et al., 1995) . The normal and virally infected matrix-degrading metalloproteases might be quite relevant cells were grown in Coon's modified Ham's F12 medium supplemented to the pathology of human thyroid tumors. In addition, it with 5% calf serum (Gibco Laboratories) and six growth factors has been shown recently that a high tumorigenic potential (1ϫ10 -10 M thyroid-stimulating hormone, 10 μg/ml insulin, 1ϫ10 -8 M hydrocortisone, 5 μg/ml human transferrin, 10 ng/ml somatostatin, is associated with elevated VEGF expression in the most 10 ng/ml glycyl-L-histidyl-L-lysine acetate). Soft agar colony assays were aggressive human thyroid tumors (Viglietto et al., 1995) . ent targets raises a question as to its function as a Transfections were performed with the calcium phosphate procedure as described (Graham and van der Eb, 1973) The 5ϫTRE-tk-CAT (Angel transcriptional activator. By fusion to a heterologous DNAet al., 1987) construct was co-transfected with a plasmid carrying the binding domain, it has been shown that Fra-1, unlike luciferase reporter gene under the control of the cytomegalovirus (CMV) c-Fos and FosB, lacks a transactivation domain (Bergers promoter, and the luciferase activity was determined (de Wet et al., et al., 1995) . Therefore, it has been proposed that its 1987) to normalize for variations of transfection efficiency in the six activity might be explained entirely by the ability to cell lines analyzed.
form stable AP-1 heterodimers. Alternatively, it can be Nuclear extracts and electrophoretic mobility shift assay speculated that Fra-1 is not devoid of its own transactivatCells were washed twice in phosphate-buffered saline (PBS) and resusing activity, but its transcriptional activation domain might pended in 10 volumes of a solution containing 10 mM HEPES pH 7.9, require extensive modification (i.e. phosphorylation), 10 mM KCl, 1.5 mM MgCl 2 , 0.1 mM EGTA, 0.5 mM dithiothreitol which could be drastically affected by transformation.
(DTT) (homogenization solution). The cells were disrupted by passage through a 26 gauge needle. Nuclei were collected by centrifugation at
The changes in morphology and anchorage-independent 1500 r.p.m. and resuspended in 1.2 volumes of extraction solution growth of the cell lines expressing the antisense fra-1 containing 10 mM HEPES pH 7.9, 0.4 M NaCl, 1.5 mM MgCl 2 , 0.1 mM show that Fra-1 is necessary for the establishment of the EGTA, 0.5 mM DTT, 5% glycerol, to allow elution of nuclear proteins transformed phenotype. Previous reports indicated that by gentle shaking at 4°C. Nuclei were pelleted again by centrifugation ectopic Fra-1 overexpression in Rat-1A cell lines was at 12 000 r.p.m. and the supernatant was stored at -70°C. The protease inhibitors leupeptin (5 mM), aprotinin (1.5 mM), phenylmethylsulfonyl sufficient to induce tumorigenicity in the absence of fluoride (2 mM), pepstatin A (3 mM) and benzamidine (1 mM) morphological transformation (Bergers et al., 1995) . In were added to both homogenization and extraction solutions. Protein the thyroid cell system, we could clearly detect the effect concentration was determined by the Bradford protein assay (Bio-Rad).
of Fra-1 inhibition on the transformed cell morphology, Nuclear extracts (2.5-5 μg of proteins) were incubated in 20 mM HEPES pH 7.5, 40 mM KCl, 5% glycerol in a volume of 20 μl containing but no effect of Fra-1 (or JunB) overexpression in normal 1 μg of poly(dI-dC) and 5 mM spermidine, for 10 min at room Speciale AIRC 'Oncosoppressori' and P.F. 'Applicazioni Cliniche della temperature. Binding reactions were incubated for 15 min after the Ricerca Oncologica' (CNR) to A.F. S.B. and L.C. were supported by addition of the probe. The sequences of the oligonucleotide probes were:
Fellowships from AIRC. D.V. was a recipient of an European Union/ AP-1 consensus TRE (collTRE), derived from the human collagenase CNR Fellowship. promoter (Lee et al., 1987) , 5Ј-TTCCGGCTGACTCATCAAGCG-3Ј; Sp1 consensus binding sequence (Briggs et al., 1986) , 5Ј-ATTCGAT-CGGGGCGGGGCGAGC-3Ј. Samples were then separated on 8% native
